Keurig Dr Pepper Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Keurig Dr Pepper Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities: | ||||||||||||||||||||||||||||||||||||||||||||
net income | -144,000,000 | 406,000,000 | 266,000,000 | -71,000,000 | 235,000,000 | 159,000,000 | 508,000,000 | 203,000,000 | 188,000,000 | 177,000,000 | 165,000,000 | 240,000,000 | 260,000,000 | 182,000,000 | 185,000,000 | 202,000,000 | 220,000,000 | 157,000,000 | 188,000,000 | 210,000,000 | 155,000,000 | 207,000,000 | 155,000,000 | 106,000,000 | 170,000,000 | 179,000,000 | 178,000,000 | 102,000,000 | 154,000,000 | 172,000,000 | 114,000,000 | 144,000,000 | 183,000,000 | 89,000,000 | 114,000,000 | 151,000,000 | 158,000,000 | 132,000,000 | -621,000,000 | 95,000,000 | ||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||
depreciation expense | 112,000,000 | 103,000,000 | 98,000,000 | 106,000,000 | 90,000,000 | 87,000,000 | 83,000,000 | 51,000,000 | 49,000,000 | 50,000,000 | 51,000,000 | 49,000,000 | 49,000,000 | 49,000,000 | 49,000,000 | 47,000,000 | 47,000,000 | 48,000,000 | 49,000,000 | 47,000,000 | 48,000,000 | 48,000,000 | 49,000,000 | 49,000,000 | 50,000,000 | 49,000,000 | 49,000,000 | 48,000,000 | 49,000,000 | 47,000,000 | 56,000,000 | 51,000,000 | 50,000,000 | 49,000,000 | 49,000,000 | 47,000,000 | 46,000,000 | 44,000,000 | 46,000,000 | 42,000,000 | 40,000,000 | 39,000,000 | 39,000,000 | 34,000,000 |
amortization of intangibles | 33,000,000 | 34,000,000 | 38,000,000 | 33,000,000 | 33,000,000 | |||||||||||||||||||||||||||||||||||||||
other amortization expense | 38,000,000 | 45,000,000 | 43,000,000 | 46,000,000 | 40,000,000 | |||||||||||||||||||||||||||||||||||||||
benefit from sales returns | 20,000,000 | 19,000,000 | 23,000,000 | 15,000,000 | 18,000,000 | 18,000,000 | 16,000,000 | |||||||||||||||||||||||||||||||||||||
deferred income taxes | -275,000,000 | 18,000,000 | -8,000,000 | 52,000,000 | -24,000,000 | -18,000,000 | 36,000,000 | -161,000,000 | 24,000,000 | 20,000,000 | -266,000,000 | 17,000,000 | 18,000,000 | 30,000,000 | 14,000,000 | 16,000,000 | 2,000,000 | 8,000,000 | 4,000,000 | 15,000,000 | 11,000,000 | 8,000,000 | 14,000,000 | 85,000,000 | 47,000,000 | 15,000,000 | 33,000,000 | 16,000,000 | 14,000,000 | 28,000,000 | -132,000,000 | -143,000,000 | -86,000,000 | 31,000,000 | 4,000,000 | 9,000,000 | 55,000,000 | 10,000,000 | 21,000,000 | 17,000,000 | -299,000,000 | 28,000,000 | ||
employee stock-based compensation expense | 22,000,000 | 30,000,000 | 9,000,000 | 20,000,000 | 23,000,000 | 11,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 6,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 9,000,000 | 13,000,000 | 11,000,000 | 11,000,000 | 9,000,000 | 10,000,000 | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 | 8,000,000 | 7,000,000 | 9,000,000 | 8,000,000 | 8,000,000 | 7,000,000 | 6,000,000 | 5,000,000 | 5,000,000 | 3,000,000 | 1,000,000 | |||||
(gain) loss on disposal of property, plant, and equipment | ||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) loss on foreign currency | -9,000,000 | |||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) loss on derivatives | 24,000,000 | |||||||||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated affiliates | ||||||||||||||||||||||||||||||||||||||||||||
earned equity from distribution arrangements | -30,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other | -11,000,000 | 11,000,000 | 6,000,000 | 10,000,000 | 10,000,000 | -16,000,000 | -8,000,000 | 32,000,000 | -8,000,000 | 9,000,000 | -18,000,000 | 8,000,000 | 2,000,000 | 4,000,000 | 8,000,000 | 33,000,000 | -25,000,000 | -25,000,000 | -3,000,000 | 14,000,000 | -4,000,000 | -17,000,000 | 3,000,000 | -4,000,000 | -19,000,000 | 0 | 11,000,000 | 5,000,000 | 3,000,000 | -9,000,000 | 4,000,000 | -16,000,000 | 7,000,000 | 0 | -3,000,000 | 8,000,000 | 4,000,000 | 3,000,000 | 6,000,000 | 0 | 3,000,000 | 1,000,000 | -4,000,000 | |
changes in assets and liabilities, excluding the effects of business acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||
trade accounts receivable | -61,000,000 | -100,000,000 | -26,000,000 | -26,000,000 | -4,000,000 | -43,000,000 | 34,000,000 | 196,000,000 | -118,000,000 | -30,000,000 | -13,000,000 | 38,000,000 | -90,000,000 | 18,000,000 | -17,000,000 | 60,000,000 | -69,000,000 | -5,000,000 | -1,000,000 | 53,000,000 | -59,000,000 | -19,000,000 | 40,000,000 | -31,000,000 | 6,000,000 | -6,000,000 | 72,000,000 | -54,000,000 | 24,000,000 | |||||||||||||||
inventories | 128,000,000 | 213,000,000 | 126,000,000 | 77,000,000 | 68,000,000 | 100,000,000 | 94,000,000 | 128,000,000 | -24,000,000 | -13,000,000 | 6,000,000 | -19,000,000 | -16,000,000 | 22,000,000 | 10,000,000 | -4,000,000 | -25,000,000 | -9,000,000 | 14,000,000 | 10,000,000 | -26,000,000 | 21,000,000 | 13,000,000 | -26,000,000 | 10,000,000 | 11,000,000 | 7,000,000 | -11,000,000 | 11,000,000 | -11,000,000 | -19,000,000 | -14,000,000 | 0 | -7,000,000 | 14,000,000 | 10,000,000 | 3,000,000 | -24,000,000 | 63,000,000 | |||||
income taxes receivable and payables | 140,000,000 | -160,000,000 | 1,000,000 | 125,000,000 | 27,000,000 | |||||||||||||||||||||||||||||||||||||||
other current and non-current assets | -23,000,000 | 36,000,000 | -139,000,000 | 58,000,000 | 17,000,000 | -10,000,000 | -85,000,000 | 11,000,000 | 19,000,000 | 2,000,000 | -82,000,000 | 41,000,000 | 44,000,000 | 4,000,000 | -81,000,000 | 4,000,000 | 13,000,000 | -66,000,000 | -1,000,000 | -1,000,000 | 26,000,000 | -45,000,000 | 22,000,000 | 28,000,000 | -71,000,000 | |||||||||||||||||||
accounts payable and accrued expenses | 79,000,000 | -463,000,000 | -111,000,000 | 226,000,000 | 124,000,000 | 22,000,000 | -185,000,000 | 23,000,000 | 22,000,000 | -19,000,000 | 56,000,000 | 59,000,000 | -42,000,000 | -47,000,000 | 67,000,000 | 10,000,000 | 50,000,000 | -78,000,000 | ||||||||||||||||||||||||||
other current and non-current liabilities | 22,000,000 | -4,000,000 | 87,000,000 | -92,000,000 | -5,000,000 | -15,000,000 | 37,000,000 | -70,000,000 | 24,000,000 | 6,000,000 | 58,000,000 | -99,000,000 | 48,000,000 | 31,000,000 | -55,000,000 | -52,000,000 | 58,000,000 | 9,000,000 | -44,000,000 | |||||||||||||||||||||||||
net change in operating assets and liabilities | 300,000,000 | -583,000,000 | -46,000,000 | 358,000,000 | 155,000,000 | 107,000,000 | -6,000,000 | -49,000,000 | -116,000,000 | |||||||||||||||||||||||||||||||||||
net cash from operating activities | 849,000,000 | 297,000,000 | 739,000,000 | 941,000,000 | 790,000,000 | 671,000,000 | 550,000,000 | 645,000,000 | 315,000,000 | 103,000,000 | 306,000,000 | 322,000,000 | 313,000,000 | 97,000,000 | 256,000,000 | 276,000,000 | 230,000,000 | 177,000,000 | 268,000,000 | 374,000,000 | 248,000,000 | 101,000,000 | 331,000,000 | 309,000,000 | 129,000,000 | 340,000,000 | 216,000,000 | 60,000,000 | 194,000,000 | 305,000,000 | 284,000,000 | -325,000,000 | 324,000,000 | 205,000,000 | 51,000,000 | 273,000,000 | 279,000,000 | 987,000,000 | 164,000,000 | 330,000,000 | 193,000,000 | 178,000,000 | 186,000,000 | 100,000,000 |
capex | 0 | 0 | -93,000,000 | -98,000,000 | -105,000,000 | -122,000,000 | -76,000,000 | 0 | -38,000,000 | -41,000,000 | -117,000,000 | -44,000,000 | -25,000,000 | -16,000,000 | -70,000,000 | -42,000,000 | -41,000,000 | -27,000,000 | -108,000,000 | -29,000,000 | -22,000,000 | -20,000,000 | -32,000,000 | -34,000,000 | -37,000,000 | -50,000,000 | -32,000,000 | -29,000,000 | -50,000,000 | -54,000,000 | -38,000,000 | -51,000,000 | -44,000,000 | -50,000,000 | -54,000,000 | -56,000,000 | -59,000,000 | -55,000,000 | -94,000,000 | -85,000,000 | -60,000,000 | -78,000,000 | -101,000,000 | -44,000,000 |
free cash flows | 849,000,000 | 297,000,000 | 646,000,000 | 843,000,000 | 685,000,000 | 549,000,000 | 474,000,000 | 645,000,000 | 277,000,000 | 62,000,000 | 189,000,000 | 278,000,000 | 288,000,000 | 81,000,000 | 186,000,000 | 234,000,000 | 189,000,000 | 150,000,000 | 160,000,000 | 345,000,000 | 226,000,000 | 81,000,000 | 299,000,000 | 275,000,000 | 92,000,000 | 290,000,000 | 184,000,000 | 31,000,000 | 144,000,000 | 251,000,000 | 246,000,000 | -376,000,000 | 280,000,000 | 155,000,000 | -3,000,000 | 217,000,000 | 220,000,000 | 932,000,000 | 70,000,000 | 245,000,000 | 133,000,000 | 100,000,000 | 85,000,000 | 56,000,000 |
investing activities: | ||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | ||||||||||||||||||||||||||||||||||||||||||||
purchases of property, plant, and equipment | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of property, plant, and equipment | ||||||||||||||||||||||||||||||||||||||||||||
purchases of intangibles | -10,000,000 | -1,000,000 | -7,000,000 | -1,000,000 | -30,000,000 | -31,000,000 | ||||||||||||||||||||||||||||||||||||||
investments in unconsolidated affiliates | 0 | -8,000,000 | -914,000,000 | -1,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -1,076,000,000 | -161,000,000 | -922,000,000 | 560,000,000 | -134,000,000 | 66,000,000 | -61,000,000 | -18,891,000,000 | -111,000,000 | -68,000,000 | -120,000,000 | -48,000,000 | -26,000,000 | -1,569,000,000 | -70,000,000 | -40,000,000 | -39,000,000 | -40,000,000 | -99,000,000 | -48,000,000 | -7,000,000 | -40,000,000 | -32,000,000 | -30,000,000 | -38,000,000 | -53,000,000 | -31,000,000 | -44,000,000 | -49,000,000 | -53,000,000 | -38,000,000 | -53,000,000 | -43,000,000 | -49,000,000 | -54,000,000 | -53,000,000 | -43,000,000 | -55,000,000 | -94,000,000 | -84,000,000 | -58,000,000 | -15,000,000 | -101,000,000 | -2,000,000 |
financing activities: | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of notes | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||
repayments of notes | ||||||||||||||||||||||||||||||||||||||||||||
net repayment of commercial paper | ||||||||||||||||||||||||||||||||||||||||||||
repayment of term loan | -330,000,000 | -84,000,000 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from structured payables | 10,000,000 | 39,000,000 | 41,000,000 | 44,000,000 | 43,000,000 | 84,000,000 | 94,000,000 | |||||||||||||||||||||||||||||||||||||
repayments of structured payables | ||||||||||||||||||||||||||||||||||||||||||||
cash dividends paid | -311,000,000 | -300,000,000 | -284,000,000 | -268,000,000 | -211,000,000 | -211,000,000 | -209,000,000 | |||||||||||||||||||||||||||||||||||||
repurchases of common stock, inclusive of excise tax obligation | ||||||||||||||||||||||||||||||||||||||||||||
tax withholdings related to net share settlements | -3,000,000 | -5,000,000 | -5,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||
payments on finance leases | -32,000,000 | -21,000,000 | -25,000,000 | -14,000,000 | -17,000,000 | -9,000,000 | ||||||||||||||||||||||||||||||||||||||
net cash from financing activities | 281,000,000 | -135,000,000 | -213,000,000 | -1,132,000,000 | -624,000,000 | -738,000,000 | -507,000,000 | 18,380,000,000 | -223,000,000 | -73,000,000 | -190,000,000 | -497,000,000 | -78,000,000 | -142,000,000 | 984,000,000 | 141,000,000 | -220,000,000 | -775,000,000 | 534,000,000 | -239,000,000 | -207,000,000 | -202,000,000 | -165,000,000 | -265,000,000 | -123,000,000 | -281,000,000 | -276,000,000 | -175,000,000 | -161,000,000 | -174,000,000 | -134,000,000 | -134,000,000 | -171,000,000 | -264,000,000 | 343,000,000 | -409,000,000 | -393,000,000 | -645,000,000 | -71,000,000 | -202,000,000 | -125,000,000 | -156,000,000 | -102,000,000 | -66,000,000 |
cash, cash equivalents, restricted cash, and restricted cash equivalents: | ||||||||||||||||||||||||||||||||||||||||||||
net change from operating, investing, and financing activities | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes | -6,000,000 | 6,000,000 | 3,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||
beginning balance | 0 | |||||||||||||||||||||||||||||||||||||||||||
ending balance | 48,000,000 | |||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow disclosures of non-cash investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||
capital expenditures included in accounts payable and accrued expenses | 56,000,000 | 80,000,000 | 34,000,000 | 9,000,000 | 25,000,000 | 3,000,000 | 8,000,000 | 25,000,000 | ||||||||||||||||||||||||||||||||||||
equity received in exchange for modification of related party contract | 0 | |||||||||||||||||||||||||||||||||||||||||||
dividends declared but not yet paid | 1,000,000 | -1,000,000 | -3,000,000 | -3,000,000 | 1,000,000 | 0 | 78,000,000 | 0 | -1,000,000 | 73,000,000 | -2,000,000 | 16,000,000 | 55,000,000 | |||||||||||||||||||||||||||||||
accrued excise tax on net share repurchases | -5,000,000 | |||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow disclosures: | ||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest | 186,000,000 | 188,000,000 | 127,000,000 | 193,000,000 | 265,000,000 | |||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | 85,000,000 | 94,000,000 | 120,000,000 | 98,000,000 | 134,000,000 | |||||||||||||||||||||||||||||||||||||||
unrealized loss on foreign currency | ||||||||||||||||||||||||||||||||||||||||||||
net issuance (repayment) of commercial paper | ||||||||||||||||||||||||||||||||||||||||||||
repurchases of common stock | -5,000,000 | -249,000,000 | -291,000,000 | |||||||||||||||||||||||||||||||||||||||||
loss on early extinguishment of debt | 0 | 0 | 0 | 2,000,000 | 0 | 0 | 13,000,000 | |||||||||||||||||||||||||||||||||||||
gain on sale of equity method investment | 0 | |||||||||||||||||||||||||||||||||||||||||||
gain on disposal of property, plant, and equipment | ||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on foreign currency | 19,000,000 | |||||||||||||||||||||||||||||||||||||||||||
unrealized loss on derivatives | 68,000,000 | -39,000,000 | ||||||||||||||||||||||||||||||||||||||||||
settlements of interest rate contracts | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
equity in (earnings) loss of unconsolidated affiliates | -9,000,000 | |||||||||||||||||||||||||||||||||||||||||||
impairment of goodwill | ||||||||||||||||||||||||||||||||||||||||||||
impairment of intangible assets | 0 | 166,000,000 | ||||||||||||||||||||||||||||||||||||||||||
impairment of investments and note receivable of unconsolidated affiliate | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of investment in unconsolidated affiliates | 0 | |||||||||||||||||||||||||||||||||||||||||||
issuance of related party note receivable | 0 | -2,000,000 | 0 | -10,000,000 | -5,000,000 | |||||||||||||||||||||||||||||||||||||||
repayment of notes | ||||||||||||||||||||||||||||||||||||||||||||
net (repayment) issuance of commercial paper | -327,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from term loan | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
payments on structured payables | -51,000,000 | -99,000,000 | ||||||||||||||||||||||||||||||||||||||||||
net change from operating, investing and financing activities | 54,000,000 | |||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses | 183,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||
transaction costs included in accounts payable and accrued expenses | -7,000,000 | |||||||||||||||||||||||||||||||||||||||||||
conversion of note receivable to equity method investment | ||||||||||||||||||||||||||||||||||||||||||||
non-cash purchases of intangibles | ||||||||||||||||||||||||||||||||||||||||||||
mandatory redemption liability | ||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of property, plant and equipment | -42,000,000 | -70,000,000 | ||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||
purchases of property, plant and equipment | -93,000,000 | -98,000,000 | -105,000,000 | -122,000,000 | -76,000,000 | -56,000,000 | -59,000,000 | -55,000,000 | -94,000,000 | -85,000,000 | -60,000,000 | -78,000,000 | -101,000,000 | -44,000,000 | ||||||||||||||||||||||||||||||
proceeds from sales of property, plant and equipment | 89,000,000 | 104,000,000 | 0 | 228,000,000 | ||||||||||||||||||||||||||||||||||||||||
supplemental cash flow disclosures of non-cash investing activities: | ||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow disclosures of non-cash financing activities: | ||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on derivatives | -4,000,000 | -8,000,000 | ||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents: | ||||||||||||||||||||||||||||||||||||||||||||
earned equity | ||||||||||||||||||||||||||||||||||||||||||||
net income attributable to kdp | 693,000,000 | 453,000,000 | 843,000,000 | |||||||||||||||||||||||||||||||||||||||||
other current and non current assets | 59,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other current and non current liabilities | -45,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of commercial paper | 698,000,000 | 650,000,000 | ||||||||||||||||||||||||||||||||||||||||||
repayments of commercial paper | -299,000,000 | -1,499,000,000 | ||||||||||||||||||||||||||||||||||||||||||
repayments of term loan | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | 0 | |||||||||||||||||||||||||||||||||||||||||||
net change from: | ||||||||||||||||||||||||||||||||||||||||||||
operating, investing and financing activities | 32,000,000 | -1,000,000 | -18,000,000 | 134,000,000 | -19,000,000 | -38,000,000 | -4,000,000 | -223,000,000 | 209,000,000 | -1,614,000,000 | 1,170,000,000 | 377,000,000 | -29,000,000 | -638,000,000 | 703,000,000 | 87,000,000 | 34,000,000 | -141,000,000 | 134,000,000 | 14,000,000 | -32,000,000 | 6,000,000 | -91,000,000 | -159,000,000 | -16,000,000 | 78,000,000 | 112,000,000 | -512,000,000 | 110,000,000 | -108,000,000 | 340,000,000 | -189,000,000 | -157,000,000 | 287,000,000 | -1,000,000 | 44,000,000 | 10,000,000 | 7,000,000 | -17,000,000 | 32,000,000 | ||||
beginning of period | ||||||||||||||||||||||||||||||||||||||||||||
end of period | ||||||||||||||||||||||||||||||||||||||||||||
non-cash investing activities: | ||||||||||||||||||||||||||||||||||||||||||||
non-cash financing activities: | ||||||||||||||||||||||||||||||||||||||||||||
impairment on investments and note receivable of unconsolidated affiliate | ||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash and cash equivalents: | ||||||||||||||||||||||||||||||||||||||||||||
non-cash conversion of note receivable to investment in unconsolidated affiliate | ||||||||||||||||||||||||||||||||||||||||||||
equity in losses of unconsolidated affiliates | ||||||||||||||||||||||||||||||||||||||||||||
impairment on investments and note receivable of unconsolidated affiliates | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from kdp revolver | ||||||||||||||||||||||||||||||||||||||||||||
repayment of kdp revolver | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from controlling shareholder stock transactions | 0 | |||||||||||||||||||||||||||||||||||||||||||
non-cash acquisition of controlling interest | 0 | |||||||||||||||||||||||||||||||||||||||||||
equity in loss of unconsolidated affiliates | ||||||||||||||||||||||||||||||||||||||||||||
repayments of 2019 kdp term loan | ||||||||||||||||||||||||||||||||||||||||||||
measurement period adjustment of core purchase price | ||||||||||||||||||||||||||||||||||||||||||||
repayments of kdp revolver | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of stock by jab | ||||||||||||||||||||||||||||||||||||||||||||
finance lease additions | 60,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from unsecured credit facility | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from senior unsecured notes | 0 | 0 | 0 | 0 | 500,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||
net payment of commercial paper | ||||||||||||||||||||||||||||||||||||||||||||
payments on notes | ||||||||||||||||||||||||||||||||||||||||||||
payments on term loan | ||||||||||||||||||||||||||||||||||||||||||||
tax witholdings related to net share settlements | ||||||||||||||||||||||||||||||||||||||||||||
gain on step acquisition of unconsolidated subsidiaries | -12,000,000 | 0 | 0 | 0 | -28,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||
(gain) loss on disposal of property, plant and equipment | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||
cash acquired in acquisitions | 19,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from capital distributions from investments in unconsolidated affiliates | ||||||||||||||||||||||||||||||||||||||||||||
net (repayment) issuance of commercial paper notes | ||||||||||||||||||||||||||||||||||||||||||||
repayment of senior unsecured notes | 0 | -314,000,000 | -391,000,000 | 0 | 0 | -500,000,000 | 0 | |||||||||||||||||||||||||||||||||||||
repayment of unsecured credit facility | 0 | |||||||||||||||||||||||||||||||||||||||||||
cash contributions from redeemable non-controlling interest shareholders | ||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock for acquisition of business | ||||||||||||||||||||||||||||||||||||||||||||
fair value of stock and replacement equity awards not converted to cash | ||||||||||||||||||||||||||||||||||||||||||||
holdback liability for acquisition of business | ||||||||||||||||||||||||||||||||||||||||||||
capitalization of related party debt into additional paid-in-capital | ||||||||||||||||||||||||||||||||||||||||||||
cash paid for related party interest | ||||||||||||||||||||||||||||||||||||||||||||
net (payment) issuance of commercial paper | ||||||||||||||||||||||||||||||||||||||||||||
payments on senior unsecured notes | ||||||||||||||||||||||||||||||||||||||||||||
payment on unsecured credit facility | ||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, restricted cash and restricted cash equivalents — net change from: | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | 35,000,000 | 1,000,000 | -3,000,000 | 1,000,000 | 2,000,000 | 3,000,000 | ||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 0 | -63,000,000 | 0 | 158,000,000 | 0 | 0 | 1,787,000,000 | |||||||||||||||||||||||||||||||||||||
cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | 17,000,000 | 21,000,000 | -20,000,000 | 121,000,000 | -222,000,000 | 211,000,000 | 176,000,000 | |||||||||||||||||||||||||||||||||||||
measurement period adjustment of core nutrition llc purchase price | ||||||||||||||||||||||||||||||||||||||||||||
impairment on investment and note receivable of unconsolidated affiliate | ||||||||||||||||||||||||||||||||||||||||||||
employee stock based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) or loss on foreign currency | ||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) or loss on derivatives | ||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of effects of acquisition: | ||||||||||||||||||||||||||||||||||||||||||||
income taxes receivable, prepaid and payables | ||||||||||||||||||||||||||||||||||||||||||||
net issuance of commercial paper notes | ||||||||||||||||||||||||||||||||||||||||||||
deferred financing charges paid | -6,000,000 | 0 | 0 | -4,000,000 | -1,000,000 | -16,000,000 | -3,000,000 | 0 | ||||||||||||||||||||||||||||||||||||
cash contributions from redeemable nci shareholders | ||||||||||||||||||||||||||||||||||||||||||||
cross currency swap | ||||||||||||||||||||||||||||||||||||||||||||
amortization expense | 85,000,000 | 124,000,000 | 11,000,000 | 9,000,000 | 6,000,000 | 8,000,000 | 6,000,000 | 11,000,000 | 9,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 10,000,000 | 9,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 10,000,000 | 10,000,000 | 9,000,000 | 9,000,000 | 9,000,000 | 10,000,000 | 9,000,000 | 9,000,000 | 6,000,000 | 5,000,000 | 8,000,000 | 9,000,000 | 9,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 14,000,000 | ||||||
proceeds from issuance of common stock private placement | ||||||||||||||||||||||||||||||||||||||||||||
net issuance of commercial paper | -306,000,000 | 54,000,000 | -4,000,000 | -80,000,000 | 85,000,000 | |||||||||||||||||||||||||||||||||||||||
balance as of january 1, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
adoption of new accounting standards | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
dividends declared, 0.15 per share | ||||||||||||||||||||||||||||||||||||||||||||
measurement period adjustment | ||||||||||||||||||||||||||||||||||||||||||||
shares issued under employee stock-based compensation plans and other | ||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation and stock options exercised | ||||||||||||||||||||||||||||||||||||||||||||
balance as of march 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
balance as of june 30, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss | ||||||||||||||||||||||||||||||||||||||||||||
shares issued under stock-based compensation plans and other | ||||||||||||||||||||||||||||||||||||||||||||
balance as of september 30, 2019 | ||||||||||||||||||||||||||||||||||||||||||||
balance as of january 1, 2018 | ||||||||||||||||||||||||||||||||||||||||||||
dividends declared | ||||||||||||||||||||||||||||||||||||||||||||
adjustment of non-controlling interests to fair value | ||||||||||||||||||||||||||||||||||||||||||||
balance as of march 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||
balance as of june 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from stock options exercised | -4,000,000 | 5,000,000 | 2,000,000 | 0 | 1,000,000 | 2,000,000 | 17,000,000 | 0 | 2,000,000 | 5,000,000 | 7,000,000 | 2,000,000 | 6,000,000 | 3,000,000 | 19,000,000 | 4,000,000 | 4,000,000 | 24,000,000 | 1,000,000 | 9,000,000 | 3,000,000 | 1,000,000 | 9,000,000 | 6,000,000 | 6,000,000 | 0 | ||||||||||||||||||
investments in unconsolidated subsidiaries | -16,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from capital distributions from investments in unconsolidated subsidiaries | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from related party note | ||||||||||||||||||||||||||||||||||||||||||||
payments on capital leases | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under compensation plans | ||||||||||||||||||||||||||||||||||||||||||||
cash contributions (distributions) from (to) redeemable nci shareholders | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||
share repurchases | ||||||||||||||||||||||||||||||||||||||||||||
deferred compensation | ||||||||||||||||||||||||||||||||||||||||||||
unrealized gain or loss on foreign currency | ||||||||||||||||||||||||||||||||||||||||||||
unrealized gain or loss on derivatives | ||||||||||||||||||||||||||||||||||||||||||||
acquisitions of business | ||||||||||||||||||||||||||||||||||||||||||||
net repayment on line of credit | ||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred revenue | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -17,000,000 | -16,000,000 | -16,000,000 | -16,000,000 | -17,000,000 | -16,000,000 | -16,000,000 | -17,000,000 | -16,000,000 | -16,000,000 | |||||||||||||||||
unrealized losses on economic hedges | ||||||||||||||||||||||||||||||||||||||||||||
other accounts receivable | -3,000,000 | -7,000,000 | 4,000,000 | -5,000,000 | 5,000,000 | 5,000,000 | 8,000,000 | 0 | -6,000,000 | 1,000,000 | -2,000,000 | 5,000,000 | 2,000,000 | -4,000,000 | -11,000,000 | 10,000,000 | -5,000,000 | 2,000,000 | -15,000,000 | -1,000,000 | 15,000,000 | |||||||||||||||||||||||
trade accounts payable | 104,000,000 | 17,000,000 | -17,000,000 | 17,000,000 | 5,000,000 | 19,000,000 | -3,000,000 | -46,000,000 | 0 | 81,000,000 | -34,000,000 | 7,000,000 | -49,000,000 | 67,000,000 | 1,000,000 | 16,000,000 | 32,000,000 | -14,000,000 | -47,000,000 | 25,000,000 | 46,000,000 | |||||||||||||||||||||||
income taxes payable | 0 | 27,000,000 | 2,000,000 | -31,000,000 | 17,000,000 | 20,000,000 | -48,000,000 | 1,000,000 | -8,000,000 | 53,000,000 | 4,000,000 | -31,000,000 | 10,000,000 | 59,000,000 | -28,000,000 | -9,000,000 | 38,000,000 | -2,000,000 | -8,000,000 | 18,000,000 | -476,000,000 | 140,000,000 | 132,000,000 | 110,000,000 | -37,000,000 | 23,000,000 | 16,000,000 | -13,000,000 | -1,000,000 | -1,000,000 | 13,000,000 | 1,000,000 | ||||||||||||
acquisition of business | -71,000,000 | -2,000,000 | -3,000,000 | -3,000,000 | -2,000,000 | -1,548,000,000 | 0 | 0 | 0 | -10,000,000 | ||||||||||||||||||||||||||||||||||
cash acquired in step acquisition of unconsolidated subsidiaries | 1,000,000 | 0 | 0 | 3,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||
purchase of property, plant and equipment | -38,000,000 | -41,000,000 | -117,000,000 | -44,000,000 | -25,000,000 | -16,000,000 | -70,000,000 | -42,000,000 | -41,000,000 | -27,000,000 | -108,000,000 | -29,000,000 | -22,000,000 | -20,000,000 | -32,000,000 | -34,000,000 | -37,000,000 | -50,000,000 | -32,000,000 | -29,000,000 | -50,000,000 | -54,000,000 | -38,000,000 | -51,000,000 | -44,000,000 | -50,000,000 | -54,000,000 | |||||||||||||||||
purchase of intangible assets | -2,000,000 | -3,000,000 | -1,000,000 | 0 | -4,000,000 | -1,000,000 | -1,000,000 | 0 | 0 | 0 | 0 | 0 | -5,000,000 | 0 | 0 | -1,000,000 | -6,000,000 | |||||||||||||||||||||||||||
investment in unconsolidated subsidiaries | 0 | -19,000,000 | 0 | -2,000,000 | 0 | -1,000,000 | 0 | 0 | 0 | -6,000,000 | 0 | |||||||||||||||||||||||||||||||||
proceeds from disposals of property, plant and equipment | 0 | 1,000,000 | 0 | 2,000,000 | 0 | 1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 8,000,000 | 1,000,000 | 10,000,000 | 1,000,000 | 0 | 0 | 1,000,000 | 1,000,000 | 1,000,000 | 4,000,000 | 1,000,000 | 0 | 0 | 1,000,000 | 5,000,000 | |||||||||||||||||||
proceeds from issuance of senior unsecured notes | 0 | 0 | 1,550,000,000 | |||||||||||||||||||||||||||||||||||||||||
repurchase of shares of common stock | -79,000,000 | -143,000,000 | -149,000,000 | -28,000,000 | -59,000,000 | -157,000,000 | -124,000,000 | -179,000,000 | -117,000,000 | -153,000,000 | -116,000,000 | -135,000,000 | -70,000,000 | -146,000,000 | -60,000,000 | -117,000,000 | -25,000,000 | -101,000,000 | -138,000,000 | -110,000,000 | -67,000,000 | -85,000,000 | -100,000,000 | -225,000,000 | -100,000,000 | -353,000,000 | -355,000,000 | -202,000,000 | ||||||||||||||||
dividends paid | -105,000,000 | -104,000,000 | -105,000,000 | -105,000,000 | -107,000,000 | -97,000,000 | -98,000,000 | -98,000,000 | -100,000,000 | -90,000,000 | -91,000,000 | -92,000,000 | -93,000,000 | -79,000,000 | -80,000,000 | -82,000,000 | -75,000,000 | -77,000,000 | -78,000,000 | -70,000,000 | -71,000,000 | -72,000,000 | -73,000,000 | -68,000,000 | -72,000,000 | -55,000,000 | -56,000,000 | -60,000,000 | -38,000,000 | -38,000,000 | ||||||||||||||
tax withholdings related to net share settlements of certain stock awards | 0 | -21,000,000 | 0 | 0 | 0 | -30,000,000 | 0 | 0 | 0 | -31,000,000 | 0 | 0 | -1,000,000 | -26,000,000 | 0 | -1,000,000 | -15,000,000 | -1,000,000 | -1,000,000 | -11,000,000 | ||||||||||||||||||||||||
premium on issuance of senior unsecured notes | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from termination of interest rate swap | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
capital lease payments | -3,000,000 | -4,000,000 | -4,000,000 | -3,000,000 | -2,000,000 | -3,000,000 | -3,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | ||||||||||||||||||||||||||||||||||
unrealized gains on economic hedges | 11,000,000 | -17,000,000 | 12,000,000 | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||
impairment of intangible asset | ||||||||||||||||||||||||||||||||||||||||||||
gain on extinguishment of multi-employer plan withdrawal liability | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
unrealized (gains) losses on economic hedges | ||||||||||||||||||||||||||||||||||||||||||||
purchase of cost method investments | ||||||||||||||||||||||||||||||||||||||||||||
premium (discount) on issuance of senior unsecured notes | 0 | |||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of year | ||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, restricted cash, and restricted cash equivalents at end of year | ||||||||||||||||||||||||||||||||||||||||||||
purchase of cost method investment | 0 | 0 | 0 | -15,000,000 | ||||||||||||||||||||||||||||||||||||||||
excess tax benefit on stock-based compensation | 0 | 1,000,000 | 1,000,000 | 20,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 19,000,000 | 1,000,000 | 0 | 8,000,000 | 0 | 2,000,000 | 4,000,000 | 0 | 1,000,000 | 2,000,000 | 13,000,000 | 1,000,000 | |||||||||||||||||||||||||
cash and cash equivalents — net change from: | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | -3,000,000 | -2,000,000 | -1,000,000 | 2,000,000 | 1,000,000 | -7,000,000 | 0 | -3,000,000 | -1,000,000 | 0 | -4,000,000 | 1,000,000 | -1,000,000 | 2,000,000 | -1,000,000 | 3,000,000 | ||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | 0 | 0 | 153,000,000 | 366,000,000 | ||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | 208,000,000 | |||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 911,000,000 | 0 | 0 | 237,000,000 | 0 | 0 | 0 | 701,000,000 | 0 | 0 | 315,000,000 | 0 | 0 | 280,000,000 | 0 | 0 | 0 | 214,000,000 | 0 | 67,000,000 | ||||||||||||||||||||||
cash and cash equivalents at end of period | 375,000,000 | -30,000,000 | 275,000,000 | 80,000,000 | 34,000,000 | 93,000,000 | 131,000,000 | 15,000,000 | 120,000,000 | 6,000,000 | 80,000,000 | 111,000,000 | 192,000,000 | 101,000,000 | -107,000,000 | 657,000,000 | -187,000,000 | -160,000,000 | 571,000,000 | -2,000,000 | 47,000,000 | 16,000,000 | 219,000,000 | -25,000,000 | 99,000,000 | |||||||||||||||||||
cash paid for shares not yet received | 40,000,000 | -90,000,000 | ||||||||||||||||||||||||||||||||||||||||||
repayment of commercial paper | ||||||||||||||||||||||||||||||||||||||||||||
capital expenditures included in other current liabilities | 5,000,000 | 68,000,000 | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||
stock issued for acquisition of business | 0 | 13,000,000 | ||||||||||||||||||||||||||||||||||||||||||
capital lease additions | 0 | 1,000,000 | 41,000,000 | 2,000,000 | 6,000,000 | |||||||||||||||||||||||||||||||||||||||
interest paid | 45,000,000 | 11,000,000 | 9,000,000 | 52,000,000 | 7,000,000 | 1,000,000 | 0 | 62,000,000 | 5,000,000 | 8,000,000 | 68,000,000 | 11,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||
income taxes paid | 73,000,000 | 52,000,000 | 89,000,000 | 59,000,000 | 502,000,000 | 73,000,000 | 97,000,000 | 28,000,000 | 107,000,000 | 71,000,000 | 13,000,000 | 72,000,000 | 70,000,000 | 20,000,000 | 24,000,000 | |||||||||||||||||||||||||||||
current and non-current deferred revenue | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from senior unsecured notes and senior unsecured credit facility | ||||||||||||||||||||||||||||||||||||||||||||
repayment of senior unsecured notes and senior unsecured credit facility | ||||||||||||||||||||||||||||||||||||||||||||
capital expenditures included in accounts payable | 41,000,000 | -1,000,000 | -6,000,000 | 39,000,000 | -6,000,000 | 6,000,000 | 15,000,000 | |||||||||||||||||||||||||||||||||||||
amortization of deferred financing costs | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 5,000,000 | 4,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||
gain on property and intangible assets | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||
trade and other accounts receivable | 54,000,000 | -55,000,000 | -26,000,000 | 47,000,000 | -48,000,000 | 10,000,000 | -35,000,000 | -9,000,000 | -7,000,000 | |||||||||||||||||||||||||||||||||||
other non-current liabilities | -6,000,000 | 9,000,000 | -1,000,000 | -7,000,000 | 3,000,000 | -1,000,000 | -24,000,000 | -14,000,000 | -9,000,000 | -3,000,000 | -7,000,000 | |||||||||||||||||||||||||||||||||
repayment of senior unsecured credit facility | 0 | 0 | -405,000,000 | -1,325,000,000 | -200,000,000 | -125,000,000 | -155,000,000 | -100,000,000 | ||||||||||||||||||||||||||||||||||||
currency translation | 1,000,000 | 2,000,000 | 2,000,000 | -3,000,000 | 4,000,000 | -1,000,000 | 3,000,000 | 6,000,000 | -2,000,000 | -8,000,000 | ||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operations: | ||||||||||||||||||||||||||||||||||||||||||||
loss on property and intangible assets | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on disposal of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
purchases of intangible assets | 0 | -2,000,000 | -5,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from disposals of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
non-cash transfer of assets | 0 | |||||||||||||||||||||||||||||||||||||||||||
other current assets | 7,000,000 | -47,000,000 | -42,000,000 | 8,000,000 | -3,000,000 | 14,000,000 | 12,000,000 | |||||||||||||||||||||||||||||||||||||
other non-current assets | -7,000,000 | -4,000,000 | -8,000,000 | -6,000,000 | -13,000,000 | -8,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||
deferred revenue | 0 | 36,000,000 | ||||||||||||||||||||||||||||||||||||||||||
non-current deferred revenue | -10,000,000 | 861,000,000 | ||||||||||||||||||||||||||||||||||||||||||
gain on disposal of intangible assets and property | 3,000,000 | -1,000,000 | 0 | -62,000,000 | ||||||||||||||||||||||||||||||||||||||||
write-off of deferred loan costs | 0 | |||||||||||||||||||||||||||||||||||||||||||
impairment of goodwill and intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||
employee stock-based expense | ||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of property and intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
related party receivable | 0 | |||||||||||||||||||||||||||||||||||||||||||
related party payable | ||||||||||||||||||||||||||||||||||||||||||||
acquisition of subsidiaries, net of cash | ||||||||||||||||||||||||||||||||||||||||||||
purchase of investments and intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
issuances of related party notes receivables | 0 | |||||||||||||||||||||||||||||||||||||||||||
repayment of related party notes receivables | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of related party long-term debt | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from bridge loan facility | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from senior unsecured credit facility | 0 | |||||||||||||||||||||||||||||||||||||||||||
repayment of related party long-term debt | 0 | |||||||||||||||||||||||||||||||||||||||||||
repayment of bridge loan facility | 0 | |||||||||||||||||||||||||||||||||||||||||||
cash distributions to cadbury | 0 | |||||||||||||||||||||||||||||||||||||||||||
change in cadbury’s net investment | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from disposals of investments and other assets | 0 | 0 | 68,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from repayment of related party notes receivables | ||||||||||||||||||||||||||||||||||||||||||||
cash distribution to cadbury | ||||||||||||||||||||||||||||||||||||||||||||
non-cash settlement related to separation from cadbury | ||||||||||||||||||||||||||||||||||||||||||||
non-cash purchase accounting adjustment related to prior year acquisitions | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from related party notes receivables | ||||||||||||||||||||||||||||||||||||||||||||
non-cash transfers of operating assets and liabilities to cadbury | ||||||||||||||||||||||||||||||||||||||||||||
non-cash transfer of pension obligation | 71,000,000 | |||||||||||||||||||||||||||||||||||||||||||
employee stock-based expense, net of tax benefit | ||||||||||||||||||||||||||||||||||||||||||||
related party payables | ||||||||||||||||||||||||||||||||||||||||||||
settlement related to separation from cadbury | ||||||||||||||||||||||||||||||||||||||||||||
purchase accounting adjustment related to prior year acquisitions | ||||||||||||||||||||||||||||||||||||||||||||
transfers of property, plant, and equipment to cadbury | ||||||||||||||||||||||||||||||||||||||||||||
transfers of operating assets and liabilities to cadbury | ||||||||||||||||||||||||||||||||||||||||||||
reduction in long-term debt from cadbury | ||||||||||||||||||||||||||||||||||||||||||||
related entities acquisition payments | ||||||||||||||||||||||||||||||||||||||||||||
note payable related to acquisition | ||||||||||||||||||||||||||||||||||||||||||||
liabilities expected to be reimbursed by cadbury | ||||||||||||||||||||||||||||||||||||||||||||
reclassifications for tax transactions | ||||||||||||||||||||||||||||||||||||||||||||
changes in: | ||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of property | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in trade accounts receivable | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||
(increase) in related party receivables | -21,000,000 | |||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in other accounts receivable | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||
(increase) in inventories | -35,000,000 | |||||||||||||||||||||||||||||||||||||||||||
(increase) in prepaid expenses other current assets | -34,000,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in other non-current assets | -11,000,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable and accrued expenses | -60,000,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in related party payables | 63,000,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in income taxes payable | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in other non-current liabilities | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||
purchases of investments and intangible assets | ||||||||||||||||||||||||||||||||||||||||||||
payments on notes receivables | 37,000,000 | |||||||||||||||||||||||||||||||||||||||||||
issuances of notes receivables | ||||||||||||||||||||||||||||||||||||||||||||
financing activities | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | 129,000,000 | |||||||||||||||||||||||||||||||||||||||||||
repayment of long-term debt | -145,000,000 | |||||||||||||||||||||||||||||||||||||||||||
change in cadbury schweppes’ net investment | -50,000,000 | |||||||||||||||||||||||||||||||||||||||||||
non-cash transfers of property, plant and equipment to other cadbury schweppes companies | ||||||||||||||||||||||||||||||||||||||||||||
non-cash transfers of operating assets and liabilities to other cadbury schweppes companies | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||
non-cash reclassifications upon fin 48 adoption |
We provide you with 20 years of cash flow statements for Keurig Dr Pepper stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Keurig Dr Pepper stock. Explore the full financial landscape of Keurig Dr Pepper stock with our expertly curated income statements.
The information provided in this report about Keurig Dr Pepper stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.